In conclusion, in patients with CHD, HSA glycation and S-thiolation have a different prevalent burden, with GLY-HSA prevailing in patients with T2DM and THIO-HSA in patients without T2DM. This evidence concerns the gene ALB and type 2 diabetes mellitus.